Optimized autologous platelet gel in the treatment of chronic wounds of diabetic foot disease

Status

Recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2100043080

Enrollment

Unknown

Registered

2021-02-04

Start date

2021-02-01

Completion date

Unknown

Last updated

2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic foot

Interventions

Control:Debridement and dressing

Therapy Group:Treatment of diabetic foot with autologous platelet gel

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Confirm that the selected patients have diabetic feet and chronic diabetic skin ulcers. Diabetes diagnosis and classification meet the 1999 WHO standards.

Exclusion criteria

Exclusion criteria: (1) DKA patients; (2) Patients with lower extremity arterial occlusion; (3) Patients with lower limb vascular malformations; (4) Patients with severe coronary heart disease, cerebral infarction, heart failure, and renal failure; (5) Patients with malignant tumors; (6) Patients using immunosuppressive agents; (7) Patients with hyperthyroidism, anxiety and depression.

Design outcomes

Primary

Measure	Time frame
Degree of wound healing;Wound healing time;Amputation rate;	—

Countries

China

Contacts

Public ContactWang Wei

Xiang'an Hospital Affiliated to Xiamen University

wwei19742007@hotmail.com+86 18359748125

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026